AI assistant
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2022
Feb 28, 2022
32814_dirs_2022-02-28_93a3d456-9d27-457f-854f-005fdd2e79c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2022-02-28
Reporting Person: Seth Kiernan (VP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-28 | Common Stock | M | 10007 | — | Acquired | 10007 | Direct |
| 2022-02-28 | Common Stock | M | 14834 | — | Acquired | 24841 | Direct |
| 2022-02-28 | Common Stock | M | 5287 | — | Acquired | 30128 | Direct |
| 2022-02-28 | Common Stock | F | 8261 | $2.85 | Disposed | 21867 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-28 | Restricted Stock Units | $ | M | 10007 | Disposed | Common Stock (10007) | Direct | |
| 2022-02-28 | Restricted Stock Units | $ | M | 14834 | Disposed | Common Stock (14834) | Direct | |
| 2022-02-28 | Restricted Stock Units | $ | M | 5287 | Disposed | Common Stock (5287) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
F4: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.